Scientific Article

Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

Growing evidence supports a role of gut-derived metabolites in nonalcoholic fatty liver disease (NAFLD), but the relation of endotoxin levels with gut permeability and NAFLD stage remains unclear. This systematic review with meta-analysis aims to provide further insights.

View online!

Soppert, J., Brandt, E.F., Heussen, N.M., Barzakova, E., Blank, L.M., Kuepfer, L., Hornef, M.W., Trebicka, J., Jankowski, J., Berres, M.L., Noels, H. Blood endotoxin levels as biomarker of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2746-2758. doi: 10.1016/j.cgh.2022.11.030. Epub 2022 Dec 5. PMID: 36470528.

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study